MedPath

comparing surfactant administration techniques: LISA vs InSurE in preterm infants with RDS

Not Applicable
Conditions
Health Condition 1: P220- Respiratory distress syndrome of newborn
Registration Number
CTRI/2022/01/039147
Lead Sponsor
Government Medical College Aurangabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

spontaneously breathing preterm infants with RDS diagnosed within 24 h of life and meeting two or more criteria for surfactant therapy from 28 weeks 0 days to 36 weeks 6 daysâ?? gestational age.

Exclusion Criteria

infants with anatomical abnormalities of upper airway; major congenital anomalies; congenital diaphragmatic hernia; trachea-esophagealfistula; choanal atresia; cleft palate; and poor respiratory efforts. Also, infants requiring intubation and invasive ventilation due to hemodynamic instability or fraction of inspired oxygen (FiO2) requirement 0.6 were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
need of mechanical ventilation within 72 hours of birthTimepoint: need of mechanical ventilation within 72 hours of birth
Secondary Outcome Measures
NameTimeMethod
Incidence of major complications, length of hospital stay, duration of mechanical ventilation, duration of NIPPV, and survival outcomeTimepoint: till discharge or death
© Copyright 2025. All Rights Reserved by MedPath